Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
about
α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia PatientsComparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyureaRelationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern IranAlternative options for DNA-based experimental therapy of β-thalassemia.The effect and side effect of hydroxyurea therapy on patients with β-thalassemia: a systematic review to December 2012.Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients.Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures.Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.Thalidomide has a significant effect in patients with thalassemia intermedia.Report on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013.Meta-analysis on effectiveness of hydroxyurea to treat transfusion-dependent beta-thalassemia.
P2860
Q33628874-874EFF2D-C8F6-4580-BDE8-433268C87EF0Q34197393-459800BD-AED7-47F8-A2D8-9BC28262A85FQ35213992-6AE76E49-BDE9-49AD-89D1-8B811EA8BA03Q35225524-901CB2DD-862E-4E6A-9878-68B7F816859DQ35793024-D9F8E880-A0AC-4FAD-BB71-21C415DE7F54Q37993118-6383AD30-E8AA-433E-9015-5E8B0402E227Q38229328-ED304359-B7D4-412A-9C0A-A90F0437A18BQ38243173-5021259E-F14D-46D8-8FCB-454A99F79D3EQ38986543-448A2A60-9DE7-4A1B-A37A-9A0BC01ED815Q39510878-7A016061-6C38-44B7-BB0B-7B0F0C3BA3E1Q39703719-22B84516-7FC6-4046-A349-BCB5CAA868CEQ40334323-2A606D67-E239-4BFD-9323-F5FFED9ACDADQ42224585-4645319E-301A-46A6-B6D8-E2C23BCF027AQ45888439-2EEBC0F9-1678-4C7B-A3C1-0F95CE8DE63BQ47828342-72DE49A2-EB78-42F3-A584-3355DA303356Q48110343-07B3E357-5AB3-444A-BCDC-27694290ADA6Q50480177-9F967D06-EC3F-4A33-A940-91C25133CC65Q53161925-A6559E34-E12E-4E98-9188-4410D6C25977
P2860
Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Hydroxyurea-induced hematologi ...... ries and review of literature.
@en
Hydroxyurea-induced hematologi ...... ries and review of literature.
@nl
type
label
Hydroxyurea-induced hematologi ...... ries and review of literature.
@en
Hydroxyurea-induced hematologi ...... ries and review of literature.
@nl
prefLabel
Hydroxyurea-induced hematologi ...... ries and review of literature.
@en
Hydroxyurea-induced hematologi ...... ries and review of literature.
@nl
P2093
P2860
P1476
Hydroxyurea-induced hematologi ...... ries and review of literature.
@en
P2093
Alireza Bagheri
Amir Abbas Hedayati-Asl
Armin Rashidi
Mohammad Ali Ehsani
Syrus Zeinali
P2860
P304
P356
10.3109/08880010903271671
P577
2009-11-01T00:00:00Z